Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 4792K) PDF+supp data (7426K) PPT slides of all figures Supplemental Material Index Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Murn, J. Articles by Gidrol, X. Search for Related Content PubMed PubMed Citation Articles by Murn, J. Articles by Gidrol, X. Pubmed/NCBI databases Gene GEO DataSet GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Social Bookmarking                            What's this?

¹ CEA, DSV, Institut de Radiobiologie Cellulaire et Moléculaire, Laboratoire d'Exploration Fonctionnelle des Génomes, Evry 91057, France
² Cancer Center, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724

CORRESPONDENCE Xavier Gidrol: xavier.gidrol{at}cea.fr

B cell receptor (BCR) signaling contributes to the pathogenesis of B cell malignancies, and most B cell lymphomas depend on BCR signals for survival. Identification of genes that restrain BCR-mediated proliferation is therefore an important goal toward improving the therapy of B cell lymphoma. Here, we identify Ptger4 as a negative feedback regulator of proliferation in response to BCR signals and show that its encoded EP4 receptor is a principal molecule conveying the growth-suppressive effect of prostaglandin E2 (PGE2). Stable knockdown of Ptger4 in B cell lymphoma markedly accelerated tumor spread in mice, whereas Ptger4 overexpression yielded significant protection. Mechanistically, we show that the intrinsic activity of Ptger4 and PGE2–EP4 signaling target a similar set of activating genes, and find Ptger4 to be significantly down-regulated in human B cell lymphoma. We postulate that Ptger4 functions in B cells as a candidate tumor suppressor whose activity is regulated by PGE2 in the microenvironment. These findings suggest that targeting EP4 receptor for prostaglandin may present a novel strategy for treatment of B cell malignancies.

© 2008 Murn et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Murn, J., Alibert, O., Wu, N., Tendil, S., Gidrol, X. (2008). Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4. JCB 183: i17-i17 [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS